• 2793 Citations
  • 29 h-Index
1988 …2018
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Pietro Bulian is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

B-Cell Chronic Lymphocytic Leukemia Medicine & Life Sciences
Interleukin-2 Receptors Medicine & Life Sciences
Survival Medicine & Life Sciences
Mutation Medicine & Life Sciences
Large Granular Lymphocytic Leukemia Medicine & Life Sciences
Reticulocytes Medicine & Life Sciences
Flow Cytometry Medicine & Life Sciences
Lymphocytes Chemical Compounds

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1988 2018

  • 2793 Citations
  • 29 h-Index
  • 86 Article
  • 3 Letter
  • 2 Chapter
  • 1 Review article
9 Citations (Scopus)

Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia

Tissino, E., Benedetti, D., Herman, S. E. M., ten Hacken, E., Ahn, I. E., Chaffee, K. G., Rossi, F. M., Bo, M. D., Bulian, P., Bomben, R., Bayer, E., Härzschel, A., Gutjahr, J. C., Postorino, M., Santinelli, E., Ayed, A., Zaja, F., Chiarenza, A., Pozzato, G., Chigaev, A. & 9 others, Sklar, L. A., Burger, J. A., Ferrajoli, A., Shanafelt, T. D., Wiestner, A., Del Poeta, G., Hartmann, T. N., Gattei, V. & Zucchetto, A., Feb 1 2018, In : Journal of Experimental Medicine. 215, 2, p. 681-697 17 p.

Research output: Contribution to journalArticle

Integrin alpha4beta1
B-Cell Chronic Lymphocytic Leukemia
B-Lymphocytes
Lymphocytosis
Integrins

Survival and Prognostic Factors in Mixed Cryoglobulinemia: Data from 246 Cases

Mazzaro, C., Maso, L. D., Mauro, E., Gattei, V., Ghersetti, M., Bulian, P., Moratelli, G., Grassi, G., Zorat, F. & Pozzato, G., May 3 2018, In : Rare Diseases. 6, 2

Research output: Contribution to journalArticle

Cryoglobulinemia
Survival
Purpura
Ribavirin
Alkylating Agents

Low-dose radiotherapy in diffuse large B-cell lymphoma

Furlan, C., Canzonieri, V., Spina, M., Michieli, M., Ermacora, A., Maestro, R., Piccinin, S., Bomben, R., Dal Bo, M., Trovo, M., Gattei, V., Tirelli, U., Franchin, G. & Bulian, P., 2017, In : Hematological Oncology. 35, 4, p. 472-479 8 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Radiotherapy
B-Lymphocytes
Germinal Center
Quality of Life
5 Citations (Scopus)

Mutational status of IGHV is the most reliable prognostic marker in trisomy 12 chronic lymphocytic leukemia

Bulian, P., Bomben, R., Dal Bo, M., Zucchetto, A., Rossi, F. M., Degan, M., Pozzo, F., Bittolo, T., Bravin, V., D’Agaro, T., Cerri, M., Chiarenza, A., Chaffee, K. G., Condoluci, A., D’Arena, G., Spina, M., Zaja, F., Pozzato, G., Di Raimondo, F., Rossi, D. & 4 others, Del Poeta, G., Gaidano, G., Shanafelt, T. D. & Gattei, V., Oct 27 2017, In : Haematologica. 102, 11, p. e443-e446

Research output: Contribution to journalLetter

5 Citations (Scopus)

Mutational status of IGHV is the most reliable prognostic marker in trisomy 12 chronic lymphocytic leukemia

Bulian, P., Bomben, R., Bo, M. D., Zucchetto, A., Rossi, F. M., Degan, M., Pozzo, F., Bittolo, T., Bravin, V., D'Agaro, T., Cerri, M., Chiarenza, A., Chaffee, K. G., Condoluci, A., D'Arena, G., Spina, M., Zaja, F., Pozzato, G., Di Raimondo, F., Rossi, D. & 4 others, Poeta, G. D., Gaidano, G., Shanafelt, T. D. & Gattei, V., Nov 2017, In : Haematologica. 102, 11, p. e443-e446

Research output: Contribution to journalArticle